Clay B. Frederick
- Molecular Biology
- Cancer Research top 10%
- Health, Toxicology and Mutagenesis top 5%
- Pharmacology top 2%
- Biomedical Engineering
- Co-authors
- Fred F. KadlubarMelvin E. AndersenJohn B. MorrisJulia S. KimbellJames S. UltmanConstance C. WeisMichael D. BentleyWilliam Shive
- Topics
- Carcinogens and Genotoxicity Assessment (9 papers)Animal testing and alternatives (5 papers)Pharmacogenetics and Drug Metabolism (4 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Clay B. Frederick
40 papers receiving 976 citations
Peers
Comparison fields: 5 of 120
- Molecular Biology 272
- Cancer Research 265
- Health, Toxicology and Mutagenesis 186
- Pharmacology 170
- Biomedical Engineering 114
Countries citing papers authored by Clay B. Frederick
This map shows the geographic impact of Clay B. Frederick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clay B. Frederick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clay B. Frederick more than expected).
Fields of papers citing papers by Clay B. Frederick
This network shows the impact of papers produced by Clay B. Frederick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clay B. Frederick. The network helps show where Clay B. Frederick may publish in the future.
Co-authorship network of co-authors of Clay B. Frederick
This figure shows the co-authorship network connecting the top 25 collaborators of Clay B. Frederick. A scholar is included among the top collaborators of Clay B. Frederick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clay B. Frederick. Clay B. Frederick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 27 | |
| 3 | 6 | |
| 4 | 8 | |
| 5 | 105 | |
| 6 | 26 | |
| 7 | 36 | |
| 8 | 22 | |
| 9 | 9 | |
| 10 | 54 | |
| 11 | 54 | |
| 12 | 2 | |
| 13 | 5 | |
| 14 | 14 | |
| 15 | 11 | |
| 16 | 66 | |
| 17 | 15 | |
| 18 | 18 | |
| 19 | 12 | |
| 20 | 8 |
About Clay B. Frederick
Clay B. Frederick is a scholar working on Chemical Health and Safety, Small Animals and Cancer Research, having authored 42 papers that have together received 1.1k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (9 papers), Animal testing and alternatives (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). The work is most often cited by research in Chemical Health and Safety (15 citations), Pharmacology (170 citations) and Cancer Research (265 citations). Clay B. Frederick has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Fred F. Kadlubar, Melvin E. Andersen, John B. Morris, Julia S. Kimbell, James S. Ultman, Constance C. Weis, Michael D. Bentley, William Shive, Kevin T. Morgan and Daniel M. Ziegler. Their work appears in journals such as Biochemistry, Diabetes and Analytical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.